All news articles for April 2019

(Image: Getty/scanrail)

Scaling down: Clinical research shifts its focus

By Maggie Lynch

Smaller company’s last year led in new drug approvals, nearly half of which were for the treatment of rare diseases, as the industry shifts away from the need to scale infrastructure, says Tufts director.

(Image: Getty/scyther5)

IVI receives $15.7m to conduct Ph III trials of typhoid vaccine

By Melissa Fassbender

The International Vaccine Institute plans to conduct a Phase III clinical trial for a typhoid conjugate vaccine as part of which it will put in place infrastructure and a robust training program, including good clinical practice training.

Follow us


View more